|
Market Closed -
OTC Markets
11:30:40 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.4400 USD | +46.67% |
|
-12.00% | -35.31% |
Company Valuation: Avenue Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99.64 | 18.98 | 5.544 | 2.133 | 4.108 | 2.165 |
| Change | - | -80.95% | -70.79% | -61.53% | 92.6% | -47.28% |
| Enterprise Value (EV) 1 | 96.51 | 15.22 | -1.164 | 0.3499 | 1.514 | -0.6895 |
| Change | - | -84.23% | -107.65% | 130.05% | 332.7% | -145.55% |
| P/E | -19.1x | -4.13x | -0.71x | -0.16x | -0.22x | -0.73x |
| PBR | 42.2x | 5.55x | 1.42x | 2.61x | 1.51x | 1.18x |
| PEG | - | 0.1x | 0x | 0x | 0x | 0x |
| Capitalization / Revenue | - | - | - | - | - | 1,542,348x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -18.5x | -4.07x | 0.14x | -0.02x | -0.13x | 0.21x |
| EV / FCF | -25.9x | -6.46x | 0.93x | -0.03x | -0.24x | 0.62x |
| FCF Yield | -3.85% | -15.5% | 107% | -3,857% | -410% | 160% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -351.1 | -247.5 | -121.9 | -73.48 | -8.996 | -0.9291 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | 1.404 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -5.213 | -3.738 | -8.043 | -14.54 | -11.28 | -3.286 |
| Net income 1 | -5.151 | -3.731 | -3.552 | -10.38 | -11.65 | -2.909 |
| Net Debt 1 | -3.132 | -3.763 | -6.708 | -1.783 | -2.594 | -2.855 |
| Reference price 2 | 6,693.7635 | 1,021.5021 | 87.0002 | 12.0750 | 2.0000 | 0.6802 |
| Nbr of stocks (in thousands) | 14.9 | 18.6 | 63.7 | 177 | 2,054 | 3,184 |
| Announcement Date | 3/31/21 | 3/25/22 | 3/31/23 | 3/18/24 | 3/31/25 | 3/30/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.34M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 39.05B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATXI Stock
- Valuation Avenue Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
